Search

Search Constraints

You searched for: Author/Creator Issa, Ghayas C.

Search Results

1. A multi-arm phase Ib/II study designed for rapid, parallel evaluation of novel immunotherapy combinations in relapsed/refractory acute myeloid leukemia. Issue 9 (29th July 2022)

3. Clinical outcomes and impact of therapeutic intervention in patients with acute myeloid leukemia who experience measurable residual disease (MRD) recurrence following MRD‐negative remission. Issue 11 (8th September 2022)

4. Comprehensive immunophenotypic study of acute myeloid leukemia with KMT2A (MLL) rearrangement in adults: A single‐institution experience. Issue 2 (28th December 2021)

5. Development of TP53 mutations over the course of therapy for acute myeloid leukemia. Issue 11 (19th August 2021)

6. Dismal outcomes of patients with relapsed/refractory Philadelphia chromosome‐negative B‐cell acute lymphoblastic leukemia after failure of both inotuzumab ozogamicin and blinatumomab. Issue 6 (17th March 2022)

7. Duration of cytopenias with concomitant venetoclax and azole antifungals in acute myeloid leukemia. Issue 14 (1st April 2021)

8. Hyper‐CVAD plus ponatinib versus hyper‐CVAD plus dasatinib as frontline therapy for patients with Philadelphia chromosome‐positive acute lymphoblastic leukemia: A propensity score analysis. Issue 23 (1st August 2016)

9. Inotuzumab ozogamicin in combination with low‐intensity chemotherapy (mini‐HCVD) with or without blinatumomab versus standard intensive chemotherapy (HCVAD) as frontline therapy for older patients with Philadelphia chromosome‐negative acute lymphoblastic leukemia: A propensity score analysis. Issue 15 (15th April 2019)